Abbott (NYSE: ABT) announced today that it launched a next-generation delivery system for its neuromodulation business.

Scientists have discovered biomarkers that can indicate how severe a spinal cord injury is and the likelihood of recovery. | ...

Researchers have used genetic tools to investigate how specific nerve cells in the brain respond after a spinal cord injury.

Researchers at the University of Ottawa have made a significant advancement in the field of spinal cord injury research, developing a novel optogenetic mouse model that could lead to improved ...